These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 14605592)
1. [Current trends in the treatment of arterial hypertension]. Parati G; Maronati A; ; Minerva Med; 2003 Aug; 94(4):273-95. PubMed ID: 14605592 [TBL] [Abstract][Full Text] [Related]
2. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk stratification according to the 2003 ESH-ESC guidelines in uncomplicated patients with essential hypertension: comparison with the 1999 WHO/ISH guidelines criteria. Cuspidi C; Meani S; Salerno M; Severgnini B; Fusi V; Valerio C; Catini E; Magrini F; Zanchetti A Blood Press; 2004; 13(3):144-51. PubMed ID: 15223722 [TBL] [Abstract][Full Text] [Related]
4. [Initial management of hypertension in a primary care service]. Nardo P; Bovier P; Pechère-Bertschi A Rev Med Suisse; 2006 Sep; 2(78):2024-6, 2029-34. PubMed ID: 17019837 [TBL] [Abstract][Full Text] [Related]
5. Total cardiovascular risk: a new treatment concept. Mancia G J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556 [TBL] [Abstract][Full Text] [Related]
6. [Clinical guidelines for detection, prevention, diagnosis and treatment of systemic arterial hypertension in Mexico (2008)]. Rosas M; Pastelín G; Vargas-Alarcón G; Martínez-Reding J; Lomelí C; Mendoza-González C; Lorenzo JA; Méndez A; Franco M; Sánchez-Lozada LG; Verdejo J; Sánchez N; Ruiz R; Férez-Santander SM; Attie F; Arch Cardiol Mex; 2008; 78 Suppl 2():S2-5-57. PubMed ID: 18928127 [TBL] [Abstract][Full Text] [Related]
7. [Assessment of cardiovascular risk in hypertensive patients: comparison among scores]. Del Colle S; Rabbia F; Mulatero P; Veglio F Ital Heart J Suppl; 2004 Sep; 5(9):694-704. PubMed ID: 15568607 [TBL] [Abstract][Full Text] [Related]
8. Management of hypertension in peripheral arterial disease: does the choice of drugs matter? Singer DR; Kite A Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):701-8. PubMed ID: 18375152 [TBL] [Abstract][Full Text] [Related]
9. [Guidelines for management of hypertension: why doesn't evidence lead to unanimity?]. Zuccalà A G Ital Nefrol; 2009; 26(2):226-35. PubMed ID: 19382079 [TBL] [Abstract][Full Text] [Related]
10. The 2004 Canadian recommendations for the management of hypertension: Part II--Therapy. Khan NA; McAlister FA; Campbell NR; Feldman RD; Rabkin S; Mahon J; Lewanczuk R; Zarnke KB; Hemmelgarn B; Lebel M; Levine M; Herbert C; Can J Cardiol; 2004 Jan; 20(1):41-54. PubMed ID: 14968142 [TBL] [Abstract][Full Text] [Related]
11. [From clinical observation to assessment of practices: guidelines for hypertension management]. Bobrie G; Durieux P; Postel-Vinay N; Plouin PF; French Society of Nephrology Nephrol Ther; 2009 Jun; 5 Suppl 4():S240-5. PubMed ID: 19596342 [TBL] [Abstract][Full Text] [Related]
12. [Recently published European and American guidelines for the diagnosis and treatment of hypertension]. van Zwieten PA; Struijker Boudier HA; de Leeuw PW Ned Tijdschr Geneeskd; 2004 May; 148(18):868-71. PubMed ID: 15152386 [TBL] [Abstract][Full Text] [Related]
13. The SaM (Screening and Monitoring) approach to cardiovascular risk-reduction in primary care--cyclic monitoring and individual treatment of patients at cardiovascular risk using the electronic medical record. Rabinowitz I; Tamir A Eur J Cardiovasc Prev Rehabil; 2005 Feb; 12(1):56-62. PubMed ID: 15703507 [TBL] [Abstract][Full Text] [Related]
14. Beyond hypertension toward guidelines for cardiovascular risk reduction. Volpe M; Alderman MH; Furberg CD; Jackson R; Kostis JB; Laragh JH; Psaty BM; Ruilope LM Am J Hypertens; 2004 Nov; 17(11 Pt 1):1068-74. PubMed ID: 15533736 [TBL] [Abstract][Full Text] [Related]
15. Advantages of new cardiovascular risk-assessment strategies in high-risk patients with hypertension. Ruilope LM; Segura J Clin Ther; 2005 Oct; 27(10):1658-68. PubMed ID: 16330303 [TBL] [Abstract][Full Text] [Related]
16. Treatment of hypertension in chronic kidney disease. Toto RD Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269 [TBL] [Abstract][Full Text] [Related]
17. The 2004 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of risk. Hemmelgarn BR; Zarnke KB; Campbell NR; Feldman RD; McKay DW; McAlister FA; Khan N; Schiffrin EL; Myers MG; Bolli P; Honos G; Lebel M; Levine M; Padwal R; Can J Cardiol; 2004 Jan; 20(1):31-40. PubMed ID: 14968141 [TBL] [Abstract][Full Text] [Related]
18. Blood pressure control and drug therapy in patients with diagnosed hypertension: a survey in Italian general practice. Filippi A; Paolini I; Innocenti F; Mazzaglia G; Battaggia A; Brignoli O J Hum Hypertens; 2009 Nov; 23(11):758-63. PubMed ID: 19242492 [TBL] [Abstract][Full Text] [Related]
19. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?]. Schmieder RE Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556 [No Abstract] [Full Text] [Related]
20. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Raum E; Lietzau S; Stegmaier C; Brenner H; Rothenbacher D Pharmacoepidemiol Drug Saf; 2008 May; 17(5):485-94. PubMed ID: 18383562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]